Cartesian Therapeutics Inc
F:1S70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cartesian Therapeutics Inc
F:1S70
|
US |
|
B
|
British American Tobacco PLC
OTC:BTAFF
|
UK |
|
M
|
Microport Scientific Corp
XBER:MSK
|
CN |
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
|
D
|
DigitalOcean Holdings Inc
XBER:0SU
|
US |
|
D
|
DBS Group Holdings Ltd
XMUN:DEVL
|
SG |
|
Sanrio Co Ltd
OTC:SNROF
|
JP |
|
Intra Energy Corporation Ltd
ASX:IEC
|
AU |
|
M
|
MicroVision Inc
XMUN:MVIN
|
US |
|
MS&AD Insurance Group Holdings Inc
F:59M
|
JP |
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
China Everbright Bank Co Ltd
F:C0V
|
CN |
|
Gibraltar Industries Inc
NASDAQ:ROCK
|
US |
|
Dai Nippon Printing Co Ltd
TSE:7912
|
JP |
|
B
|
Blue Label Telecoms Ltd
JSE:BLU
|
ZA |
|
L
|
LivePerson Inc
F:LVO
|
US |
|
Molson Coors Beverage Co
F:NY70
|
US |
|
V
|
Vodafone Group PLC
BMV:VODN
|
UK |
|
C
|
Canfor Corp
XBER:NKC
|
CA |
Bankruptcy Probability
Cartesian Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cartesian Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
243.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
358.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
48.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cartesian Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cartesian Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
